Press Releases

All Releases
Yield10 Bioscience, Inc. Presentation Now Available for On-Demand Viewing
April 10, 2017
Company invites individual and institutional investors as well as advisors to log-on to to view presentation WOBURN, Mass. , April 10, 2017 /CNW/ --  Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a company focused on developing new technologies to achieve step-change
Yield10 Bioscience to Host Webcast of its 2016 Year-end Conference Call
March 14, 2017
WOBURN, Mass. , March 14, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Company plans to release its fourth quarter 2016 financial results and host a conference call with management after market close on Wednesday, March 22, 2017 .
Yield10 Bioscience to Present at 29th Annual ROTH Conference
March 6, 2017
WOBURN, Mass. , March 06, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that Oliver Peoples , Ph.D., President and Chief Executive Officer, will present at the 29 th Annual ROTH Conference on Wednesday, March 15, 2017 at 9:00 am PT (12:00 noon ET ).
Yield10 Bioscience Expands Scientific Team with Two Key Hires
February 16, 2017
WOBURN, Mass. , Feb. 16, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) today announced that it has expanded its plant science team with two key hires. Karen Bohmert-Tatarev, Ph.D. has joined Yield10 as Technology Manager and Frank Skraly , Ph.D.
Yield10 Bioscience to Host Investor Conference Call
January 24, 2017
WOBURN, Mass. , Jan. 24, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ) announced today that the Company will host a conference call and live webcast on Thursday, January 26 th  to provide  investors with a presentation on the highlights of the 2016 Camelina Field Test results
Metabolix, Inc. Announces Name Change to Yield10 Bioscience, Inc.  
January 6, 2017
WOBURN, Mass. , Jan. 06, 2017 (GLOBE NEWSWIRE) -- Metabolix, Inc. ( NASDAQ : MBLX), announced today that the Company is changing its name to Yield10 Bioscience, Inc. , effective January 9, 2017 to reflect the new mission and strategic direction of the business.   Yield10 will focus on developing
Metabolix Completes $10 Million Sale of Biopolymer Assets to CJ CheilJedang
September 19, 2016
WOBURN, Mass. , Sept. 19, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX) announced today that it has completed the sale of its biopolymer intellectual property and certain equipment and inventory to an affiliate of CJ CheilJedang Corporation ("CJ") for a total purchase price of $10 million
Displaying 61 - 80 of 80